NEW YORK (GenomeWeb) – After launching the "world's smallest" PCR-based diagnostic device less than two months ago, Spartan Bioscience this week announced the first official test on the system — a 30-minute cheek swab assay for mutations in the apolipoprotein E (APOE) gene.

The target market for the research-use only test is pharmaceutical companies, to help focus and speed up Alzheimer's disease-related clinical trials, Spartan's CEO Paul Lem said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.